AB
BIVV

Amalgamated Bank’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Amalgamated Bank’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-22,800
Closed -$1.23M – 1669
2017
Q4 		$1.23M Buy
22,800
+1,205
+6% +$65.9K 0.03% 612
2017
Q3 		$1.23M Sell
21,595
-271
-1% -$15.9K 0.04% 533
2017
Q2 		$1.32M Buy
21,866
+13,694
+168% +$780K 0.04% 481
2017
Q1 		$445K Buy
+8,172
New +$403K 0.02% 903

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Amalgamated Bank's BIVV Position: Q1 2018 in Review

Amalgamated Bank sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 22,800 shares — an estimated $1.23M sold.

Amalgamated Bank first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.32M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Amalgamated Bank reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Amalgamated Bank sold 22,800 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.23M.
  • Amalgamated Bank first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Amalgamated Bank's Bioverativ Inc. Common Stock position peaked at $1.32M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Amalgamated Bank's 13F filing for Q1 2018, filed 22 May 2018.